Page 42 - TD-4-2
P. 42

Tumor Discovery                                               Understanding glioblastoma invasion and therapy



               Inskip PD, Johnson KJ, Rajaraman P. Ionizing radiation   27.  WHO International Agency for Research on Cancer. World
               and the risk of brain and central nervous system tumors: A   Health Organization Classification of Tumours of the Central
                                                                                th
               systematic review. Neuro Oncol. 2012;14(11):1316-1324.  Nervous System. 4  ed. Lyon, France: WHO International
                                                                  Agency for Research on Cancer; 2016.
               doi: 10.1093/neuonc/nos208
                                                               28.  Horbinski C, Ligon KL, Brastianos P,  et al. The medical
            16.  Ostrom QT, Adel Fahmideh M, Cote DJ, et al. Risk factors   necessity of advanced molecular testing in the diagnosis
               for childhood and adult primary brain tumors. Neuro Oncol.   and treatment of brain tumor patients.  Neuro Oncol.
               2019;21(11):1357-1375.
                                                                  2019;21(12):1498-1508.
               doi: 10.1093/neuonc/noz123                         doi: 10.1093/neuonc/noz119
            17.  Kinnersley B, Mitchell JS, Gousias K, et al. Quantifying the   29.  Louis DN, Aldape K, Brat DJ, et al. Announcing cIMPACT-
               heritability of glioma using genome-wide complex trait   NOW: The consortium to inform molecular and practical
               analysis. Sci Rep. 2015;5:17267.                   approaches to CNS tumor taxonomy.  Acta Neuropathol.
               doi: 10.1038/srep17267                             2017;133(1):1-3.
            18.  Wrensch M, Lee M, Miike R, et al. Familial and personal      doi: 10.1007/s00401-016-1646-x
               medical history of cancer and nervous system conditions   30.  Weller  M,  van  den  Bent  M,  Preusser  M,  et al.  EANO
               among adults with glioma and controls.  Am J Epidemiol.   guidelines on the diagnosis and treatment of diffuse gliomas
               1997;145(7):581-593.                               of adulthood. Nat Rev Clin Oncol. 2021;18(3):170-186.
               doi: 10.1093/oxfordjournals.aje.a009154            doi: 10.1038/s41571-020-00447-z
            19.  Kumar  VA,  Abbas  AK,  Aster  JC.  Neoplasia.  In:  Robbins   31.  Ohgaki H, Kleihues P. The definition of primary and secondary
               and Cotran Pathological Basis of Disease.  9   ed.,  Ch.  7.   glioblastoma. Clin Cancer Res. 2013;19(4):764-772.
                                                th
               Amsterdam,  Netherlands:  Elsevier  Health  Sciences;  2014.
               p. 265-340.                                        doi: 10.1158/1078-0432.Ccr-12-3002
            20.  Pedersen PH, Rucklidge GJ, Mørk SJ, et al. Leptomeningeal   32.  Guo C, Pirozzi CJ, Lopez GY, Yan H. Isocitrate dehydrogenase
               tissue: A  barrier against brain tumor cell invasion.  J  Natl   mutations in gliomas: Mechanisms, biomarkers and
               Cancer Inst. 1994;86(21):1593-1599.                therapeutic target. Curr Opin Neurol. 2011;24(6):648-652.
                                                                  doi: 10.1097/WCO.0b013e32834cd415
               doi: 10.1093/jnci/86.21.1593
                                                               33.  Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing
            21.  Louveau A, Herz J, Alme MN, et al. CNS lymphatic drainage   and benefit from temozolomide in glioblastoma. N Engl J
               and neuroinflammation are regulated by meningeal
               lymphatic vasculature. Nat Neurosci. 2018;21(10):1380-1391.  Med. 2005;352(10):997-1003.
                                                                  doi: 10.1056/NEJMoa043331
               doi: 10.1038/s41593-018-0227-9
                                                               34.  Alexander BM, Cloughesy TF. Adult glioblastoma.  J  Clin
            22.  Houston SC, Crocker IR, Brat DJ, Olson JJ. Extraneural   Oncol. 2017;35(21):2402-2409.
               metastatic glioblastoma after interstitial brachytherapy. Int
               J Radiat Oncol Biol Phys. 2000;48(3):831-836.      doi: 10.1200/jco.2017.73.0119
               doi: 10.1016/s0360-3016(00)00662-3              35.  Chaichana KL, Parker SL, Olivi A, Quiñones-Hinojosa A.
                                                                  Long-term seizure outcomes in adult patients undergoing
            23.  WHO International Agency for Research on Cancer. World   primary resection of malignant brain astrocytomas. Clinical
               Health Organization Classification of Tumours of the Central   article. J Neurosurg. 2009;111(2):282-292.
               Nervous System. 5  ed. Lyon, France: WHO International
                             th
               Agency for Research on Cancer; 2021.               doi: 10.3171/2009.2.JNS081132
            24.  Wesseling P, Kros JM, Jeuken JWM. The pathological diagnosis   36.  Bohman LE, Swanson KR, Moore JL,  et al. Magnetic
               of diffuse gliomas: Towards a smart synthesis of microscopic   resonance imaging characteristics of glioblastoma
               and molecular information in a multidisciplinary context.   multiforme: Implications for  understanding  glioma
               Diagn Histopathol. 2011;17(11):486-494.            ontogeny. Neurosurgery. 2010;67(5):1319-1328.
               doi: 10.1016/j.mpdhp.2011.08.005                   doi: 10.1227/NEU.0b013e3181f556ab
            25.  Yachnis, AT, Rivera-Zengotita, ML. Diffuse gliomas:   37.  Brown TJ, Brennan MC, Li M, et al. Association of the extent of
               Astrocytic. In Neuropathology. United States: Elsevier   resection with survival in glioblastoma: A systematic review
               Sanders; 2014. p. 72-83.                           and meta-analysis. JAMA Oncol. 2016;2(11):1460-1469.
            26.  Kumar V, Abbas, AK, Aster JC. Robbins and Cotran Pathologic      doi: 10.1001/jamaoncol.2016.1373
                             th
               Basis of Disease. 10  ed. Amsterdam, Netherlands: Elsevier-  38.  Grabowski MM, Recinos PF, Nowacki AS,  et al. Residual
               OHCE; 2020.                                        tumor volume versus extent of resection: Predictors

            Volume 4 Issue 2 (2025)                         34                                doi: 10.36922/td.8578
   37   38   39   40   41   42   43   44   45   46   47